WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.

WITHDRAWN: Selective serotonin reuptake inhibitors (SSRIs) versus other antidepressants for depression.

BACKGROUND: The relatively new class of antidepressant, the selective serotonin reputake inhibitors (SSRIs), may be better tolerated than the older tricyclic antidepressants. This review compares the efficacy of SSRIs with other antidepressants. OBJECTIVES: To examine the relative efficacy of selec...

Full description

Bibliographic Details
Main Authors:	Geddes, J, Freemantle, N, Mason, J, Eccles, M, Boynton, J
Format:	Journal article
Language:	English
Published:	2006

Similar Items

WITHDRAWN: Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs).
by: Barbui, C, et al.
Published: (2006)

Treatment discontinuation with selective serotonin reuptake inhibitors (SSRIs) versus tricyclic antidepressants (TCAs) (Withdrawn Paper. 2006, art no. CD002791)
by: Barbui, C, et al.
Published: (2006)

SSRIs versus other antidepressants for depressive disorder.
by: Geddes, J, et al.
Published: (2000)

Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence.
by: Barbui, C, et al.
Published: (2000)

Secondary and side effects of particular Selective Serotonin Reuptake Inhibitors (SSRIs) antidepressants - literature review
by: Ewa Krzewicka-Romaniuk, et al.
Published: (2020-09-01)

A comparative study of personality aspects of females with depression using the antidepressant medications: selective serotonin reuptake inhibitors (SSRIs) and tricyclic antidepressants (TCAs)
by: Saeed Pournaghash tehrani, et al.
Published: (2018-03-01)

Early onset of selective serotonin reuptake inhibitor antidepressant action: systematic review and meta-analysis.
by: Taylor, M, et al.
Published: (2006)

Early effects of selective serotonin reuptake inhibitors (SSRIs) on cornea and lens density in patients with depression
by: Yalçın Karaküçük, et al.
Published: (2019-10-01)

In-hospital predictors of post-stroke depression for targeted initiation of Selective Serotonin Reuptake Inhibitors (SSRIs)
by: Julie Yi, et al.
Published: (2022-11-01)

Selective serotonin reuptake inhibitors and violent crime: do SSRI’s kill or cure?
by: S. Sneep, et al.
Published: (2022-06-01)

Pindolol augmentation of serotonin reuptake inhibitors for the treatment of depressive disorder: a systematic review.
by: Whale, R, et al.
Published: (2010)

Selective serotonin reuptake inhibitors.
by: Geddes, J, et al.
Published: (2004)

Using functional neuroimaging to investigate the mechanisms of action of selective serotonin reuptake inhibitors (SSRIs).
by: Murphy, SE
Published: (2010)

Efficacy of Selective Serotonin Reuptake Inhibitors (SSRIS) compared to placebo in obsessive compulsive disorder in adults
by: Soomro, G, et al.
Published: (2008)

Review on Surface-Modified Electrodes for the Enhanced Electrochemical Detection of Selective Serotonin Reuptake Inhibitors (SSRIs)
by: Simone C. L. Barry, et al.
Published: (2023-06-01)

Potential Adverse Cardiovascular Effects of Treatment With Fluoxetine and Other Selective Serotonin Reuptake Inhibitors (SSRIs) in Patients With Geriatric Depression: Implications for Atherogenesis and Cerebromicrovascular Dysregulation
by: Zoltan Ungvari, et al.
Published: (2019-09-01)

Evaluating the Use of Selective Serotonin Reuptake Inhibitors (SSRIs) and Male Infertility: A Critical Retrospective Study
by: Jawza F. Alsabhan, et al.
Published: (2024-04-01)

Adjunct Triptorelin in the Treatment of Obsessive-Compulsive Disorder in Clients Receiving Selective Serotonin Reuptake Inhibitors (SSRIs)
by: Faezeh Nikzad, et al.
Published: (2021-09-01)

The impacts of the “4+7” pilot policy on the volume, expenditures, and daily cost of Serotonin-Specific Reuptake Inhibitors (SSRIs) antidepressants: A quasi-experimental study
by: Xiaotong Wen, et al.
Published: (2022-08-01)

Analytical methods for determination of selective serotonin reuptake inhibitor antidepressants
by: Şentürk Zühre, et al.
Published: (2011-06-01)

Review of the Knowledge on Selective Serotonin Reuptake Inhibitors (SSRIs) for Depression Management by Residents and Concurrent Physicians of the Medical Clinic of 5 Hospitals in CABA
by: Gonzalo E. Barbosa Eyler, et al.
Published: (2023-09-01)

Serotonin selective reuptake inhibitors (SSRIs) and female sexual dysfunction (FSD): hypothesis on its association and options of treatment
by: Mahamad Rappek, Nurul Azmi, et al.
Published: (2018)

Antidepressants are selective serotonin neuronal reuptake inhibitors: 40-year history
by: D. S. Danilov
Published: (2015-03-01)

Selective serotonin reuptake inhibitor (SSRI) antidepressants, prolactin and breast cancer
by: Janet eAshbury, et al.
Published: (2012-12-01)

Serotonin reuptake inhibitors in Obsessive-Compulsive Disorder: antidepressant or antiobsessional agents?
by: Giuseppe Maina, et al.
Published: (2009-03-01)

Selective Serotonin Reuptake Inhibitors (SSRIs) and the Risk of Congenital Heart Defects: A Meta‐Analysis of Prospective Cohort Studies
by: Shang Wang, et al.
Published: (2015-05-01)

Myoclonus as a Single Side Effect of Combination of Selective Serotonin Reuptake Inhibitors (SSRIs) and Clomipramine: Three Case Reports
by: Reza Mohseni-Bandpey, et al.
Published: (2020-07-01)

Selective serotonin reuptake inhibitors (SSRIs) prevent meta-iodobenzylguanidine (MIBG) uptake in platelets without affecting neuroblastoma tumor uptake
by: Thomas Blom, et al.
Published: (2020-07-01)

Is the Antidepressant Activity of Selective Serotonin Reuptake Inhibitors Mediated by Nicotinic Acetylcholine Receptors?
by: Hugo R. Arias, et al.
Published: (2021-04-01)

Medical resource use and cost of venlafaxine or tricyclic antidepressant therapy. Following selective serotonin reuptake inhibitor therapy for depression.
by: Griffiths, R, et al.
Published: (1999)

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder
by: James M Martinez, et al.
Published: (2015-05-01)

The Association between Selective Serotonin Reuptake Inhibitors (SSRIs) Use and the Risk of Bladder Cancer: A Nationwide Population-Based Cohort Study
by: Yi-Chun Liu, et al.
Published: (2020-05-01)

Selective serotonin reuptake inhibitors
Published: (2004)

Pharmacovigilance of serotonin reuptake inhibitors
by: Darpan Kaur, et al.
Published: (2013-01-01)

Sentiment Analysis of Online Reviews for Selective Serotonin Reuptake Inhibitors and Serotonin–Norepinephrine Reuptake Inhibitors
by: Chad Compagner, et al.
Published: (2021-01-01)

Safety and Efficacy of Drug Holidays for Women with Sexual Dysfunction Induced by Selective Serotonin Reuptake Inhibitors (SSRIs) Other than Fluoxetine: An Open-Label Randomized Clinical Trial
by: Elham Lalegani, et al.
Published: (2023-09-01)

Selective serotonin reuptake inhibitors. Drugs related to tricyclic antidepressants are a mixed bag.
by: Cowen, P, et al.
Published: (1994)

Difficulty in Repurposing Selective Serotonin Reuptake Inhibitors and Other Antidepressants with Functional Inhibition of Acid Sphingomyelinase in COVID-19 Infection
by: Pascal Le Corre, et al.
Published: (2022-03-01)

Improvement of social adaptation in depression with serotonin and norepinephrine reuptake inhibitors
by: Mike Briley, et al.
Published: (2010-09-01)

Pre-clinical drug-drug interactions (DDIs) of gefitinib with/without losartan and selective serotonin reuptake inhibitors (SSRIs): citalopram, fluoxetine, fluvoxamine, paroxetine, sertraline, and venlafaxine
by: Thu-Lan T. Luong, et al.
Published: (2022-01-01)